APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithyroid Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antithyroid Drug Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchAntithyroid Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithyroid Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Antithyroid Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithyroid Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithyroid Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antithyroid Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antithyroid Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antithyroid Drug market include Avet Pharmaceuticals Inc., Par Pharmaceutical, Zhaohui Pharmaceutical, Hemony Pharmaceutical, Pfizer Inc, Merck KGaA, Teva Pharmaceuticals and YanJing Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antithyroid Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antithyroid Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antithyroid Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antithyroid Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Antithyroid Drug Segment by Company

Avet Pharmaceuticals Inc.

Par Pharmaceutical

Zhaohui Pharmaceutical

Hemony Pharmaceutical

Pfizer Inc

Merck KGaA

Teva Pharmaceuticals

YanJing Pharm

Antithyroid Drug Segment by Type

Methimazole

Propylthiouracil

Other

Antithyroid Drug Segment by Application

Hospital

Pharmacy

Other

Antithyroid Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antithyroid Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antithyroid Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antithyroid Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Antithyroid Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antithyroid Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antithyroid Drug industry.

Chapter 3: Detailed analysis of Antithyroid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antithyroid Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antithyroid Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antithyroid Drug Industry Trends Table 2. Antithyroid Drug Industry Drivers Table 3. Antithyroid Drug Industry Opportunities and Challenges Table 4. Antithyroid Drug Industry Restraints Table 5. Global Antithyroid Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antithyroid Drug Revenue Share by Company (2021-2026) Table 7. Global Antithyroid Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antithyroid Drug Sales Volume Share by Company (2021-2026) Table 9. Global Antithyroid Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antithyroid Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antithyroid Drug Key Company Manufacturing Base & Headquarters Table 12. Global Antithyroid Drug Company, Product Type & Application Table 13. Global Antithyroid Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antithyroid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Methimazole Table 18. Significant Companies of Propylthiouracil Table 19. Significant Companies of Other Table 20. Global Antithyroid Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Antithyroid Drug Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Antithyroid Drug Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Antithyroid Drug Sales Volume Share by Type (2021-2026) Table 24. Global Antithyroid Drug Sales Volume Share by Type (2027-2032) Table 25. Global Antithyroid Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antithyroid Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Antithyroid Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Antithyroid Drug Sales Value Share by Type (2021-2026) Table 29. Global Antithyroid Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Other Table 33. Global Antithyroid Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Antithyroid Drug Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Antithyroid Drug Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Antithyroid Drug Sales Volume Share by Application (2021-2026) Table 37. Global Antithyroid Drug Sales Volume Share by Application (2027-2032) Table 38. Global Antithyroid Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Antithyroid Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Antithyroid Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Antithyroid Drug Sales Value Share by Application (2021-2026) Table 42. Global Antithyroid Drug Sales Value Share by Application (2027-2032) Table 43. Global Antithyroid Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Antithyroid Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Antithyroid Drug Sales Market Share by Region (2021-2026) Table 46. Global Antithyroid Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Antithyroid Drug Sales Market Share by Region (2027-2032) Table 48. Global Antithyroid Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Antithyroid Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Antithyroid Drug Sales Value Share by Region (2021-2026) Table 51. Global Antithyroid Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Antithyroid Drug Sales Value Share by Region (2027-2032) Table 53. Global Antithyroid Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Antithyroid Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Antithyroid Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 58. Global Antithyroid Drug Sales Market Share by Country (2021-2026) Table 59. Global Antithyroid Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Antithyroid Drug Sales Market Share by Country (2027-2032) Table 61. Global Antithyroid Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Antithyroid Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Antithyroid Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Antithyroid Drug Sales Value Market Share by Country (2027-2032) Table 65. Avet Pharmaceuticals Inc. Company Information Table 66. Avet Pharmaceuticals Inc. Business Overview Table 67. Avet Pharmaceuticals Inc. Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio Table 69. Avet Pharmaceuticals Inc. Recent Development Table 70. Par Pharmaceutical Company Information Table 71. Par Pharmaceutical Business Overview Table 72. Par Pharmaceutical Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Par Pharmaceutical Antithyroid Drug Product Portfolio Table 74. Par Pharmaceutical Recent Development Table 75. Zhaohui Pharmaceutical Company Information Table 76. Zhaohui Pharmaceutical Business Overview Table 77. Zhaohui Pharmaceutical Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio Table 79. Zhaohui Pharmaceutical Recent Development Table 80. Hemony Pharmaceutical Company Information Table 81. Hemony Pharmaceutical Business Overview Table 82. Hemony Pharmaceutical Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Hemony Pharmaceutical Antithyroid Drug Product Portfolio Table 84. Hemony Pharmaceutical Recent Development Table 85. Pfizer Inc Company Information Table 86. Pfizer Inc Business Overview Table 87. Pfizer Inc Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Inc Antithyroid Drug Product Portfolio Table 89. Pfizer Inc Recent Development Table 90. Merck KGaA Company Information Table 91. Merck KGaA Business Overview Table 92. Merck KGaA Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merck KGaA Antithyroid Drug Product Portfolio Table 94. Merck KGaA Recent Development Table 95. Teva Pharmaceuticals Company Information Table 96. Teva Pharmaceuticals Business Overview Table 97. Teva Pharmaceuticals Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Teva Pharmaceuticals Antithyroid Drug Product Portfolio Table 99. Teva Pharmaceuticals Recent Development Table 100. YanJing Pharm Company Information Table 101. YanJing Pharm Business Overview Table 102. YanJing Pharm Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. YanJing Pharm Antithyroid Drug Product Portfolio Table 104. YanJing Pharm Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Antithyroid Drug Distributors List Table 108. Antithyroid Drug Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Antithyroid Drug Product Image Figure 2. Global Antithyroid Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithyroid Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antithyroid Drug Sales (2021-2032) & (K Units) Figure 5. Global Antithyroid Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antithyroid Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Methimazole Image Figure 10. Propylthiouracil Image Figure 11. Other Image Figure 12. Global Antithyroid Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Antithyroid Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Antithyroid Drug Sales Volume Share by Type (2021-2032) Figure 15. Global Antithyroid Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antithyroid Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antithyroid Drug Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Other Image Figure 21. Global Antithyroid Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Antithyroid Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Antithyroid Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Antithyroid Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Antithyroid Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Antithyroid Drug Sales Value Share by Application (2021-2032) Figure 27. Global Antithyroid Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Antithyroid Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Antithyroid Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Antithyroid Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Antithyroid Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Antithyroid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Antithyroid Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Antithyroid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Antithyroid Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Antithyroid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Antithyroid Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Antithyroid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Antithyroid Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Antithyroid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Antithyroid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Antithyroid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Antithyroid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Antithyroid Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Antithyroid Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Methimazole
  • Propylthiouracil
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Avet Pharmaceuticals Inc.
  • Par Pharmaceutical
  • Zhaohui Pharmaceutical
  • Hemony Pharmaceutical
  • Pfizer Inc
  • Merck KGaA
  • Teva Pharmaceuticals
  • YanJing Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antithyroid Drug Sales Value (2021-2032)
  4. 1.2.2 Global Antithyroid Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Antithyroid Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antithyroid Drug Market Dynamics
  1. 2.1 Antithyroid Drug Industry Trends
  2. 2.2 Antithyroid Drug Industry Drivers
  3. 2.3 Antithyroid Drug Industry Opportunities and Challenges
  4. 2.4 Antithyroid Drug Industry Restraints
3 Antithyroid Drug Market by Company
  1. 3.1 Global Antithyroid Drug Company Revenue Ranking in 2025
  2. 3.2 Global Antithyroid Drug Revenue by Company (2021-2026)
  3. 3.3 Global Antithyroid Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Antithyroid Drug Average Price by Company (2021-2026)
  5. 3.5 Global Antithyroid Drug Company Ranking (2024-2026)
  6. 3.6 Global Antithyroid Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Antithyroid Drug Company Product Type and Application
  8. 3.8 Global Antithyroid Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antithyroid Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antithyroid Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antithyroid Drug Market by Type
  1. 4.1 Antithyroid Drug Type Introduction
  2. 4.1.1 Methimazole
  3. 4.1.2 Propylthiouracil
  4. 4.1.3 Other
  5. 4.2 Global Antithyroid Drug Sales Volume by Type
  6. 4.2.1 Global Antithyroid Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antithyroid Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Antithyroid Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Antithyroid Drug Sales Value by Type
  10. 4.3.1 Global Antithyroid Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antithyroid Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global Antithyroid Drug Sales Value Share by Type (2021-2032)
5 Antithyroid Drug Market by Application
  1. 5.1 Antithyroid Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Antithyroid Drug Sales Volume by Application
  6. 5.2.1 Global Antithyroid Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antithyroid Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Antithyroid Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Antithyroid Drug Sales Value by Application
  10. 5.3.1 Global Antithyroid Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antithyroid Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Antithyroid Drug Sales Value Share by Application (2021-2032)
6 Antithyroid Drug Regional Sales and Value Analysis
  1. 6.1 Global Antithyroid Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antithyroid Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Antithyroid Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Antithyroid Drug Sales by Region (2027-2032)
  5. 6.3 Global Antithyroid Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antithyroid Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antithyroid Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antithyroid Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Antithyroid Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antithyroid Drug Sales Value (2021-2032)
  12. 6.6.2 North America Antithyroid Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antithyroid Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Antithyroid Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antithyroid Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antithyroid Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antithyroid Drug Sales Value (2021-2032)
  21. 6.9.2 South America Antithyroid Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antithyroid Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antithyroid Drug Sales Value Share by Country, 2025 VS 2032
7 Antithyroid Drug Country-level Sales and Value Analysis
  1. 7.1 Global Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antithyroid Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antithyroid Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Antithyroid Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Antithyroid Drug Sales by Country (2027-2032)
  6. 7.4 Global Antithyroid Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antithyroid Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antithyroid Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antithyroid Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antithyroid Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antithyroid Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antithyroid Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antithyroid Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antithyroid Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antithyroid Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antithyroid Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antithyroid Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antithyroid Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antithyroid Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antithyroid Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antithyroid Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antithyroid Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antithyroid Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antithyroid Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antithyroid Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antithyroid Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antithyroid Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antithyroid Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antithyroid Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antithyroid Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antithyroid Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antithyroid Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antithyroid Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antithyroid Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antithyroid Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antithyroid Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antithyroid Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antithyroid Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Avet Pharmaceuticals Inc.
  2. 8.1.1 Avet Pharmaceuticals Inc. Company Information
  3. 8.1.2 Avet Pharmaceuticals Inc. Business Overview
  4. 8.1.3 Avet Pharmaceuticals Inc. Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio
  6. 8.1.5 Avet Pharmaceuticals Inc. Recent Developments
  7. 8.2 Par Pharmaceutical
  8. 8.2.1 Par Pharmaceutical Company Information
  9. 8.2.2 Par Pharmaceutical Business Overview
  10. 8.2.3 Par Pharmaceutical Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Par Pharmaceutical Antithyroid Drug Product Portfolio
  12. 8.2.5 Par Pharmaceutical Recent Developments
  13. 8.3 Zhaohui Pharmaceutical
  14. 8.3.1 Zhaohui Pharmaceutical Company Information
  15. 8.3.2 Zhaohui Pharmaceutical Business Overview
  16. 8.3.3 Zhaohui Pharmaceutical Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio
  18. 8.3.5 Zhaohui Pharmaceutical Recent Developments
  19. 8.4 Hemony Pharmaceutical
  20. 8.4.1 Hemony Pharmaceutical Company Information
  21. 8.4.2 Hemony Pharmaceutical Business Overview
  22. 8.4.3 Hemony Pharmaceutical Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hemony Pharmaceutical Antithyroid Drug Product Portfolio
  24. 8.4.5 Hemony Pharmaceutical Recent Developments
  25. 8.5 Pfizer Inc
  26. 8.5.1 Pfizer Inc Company Information
  27. 8.5.2 Pfizer Inc Business Overview
  28. 8.5.3 Pfizer Inc Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Inc Antithyroid Drug Product Portfolio
  30. 8.5.5 Pfizer Inc Recent Developments
  31. 8.6 Merck KGaA
  32. 8.6.1 Merck KGaA Company Information
  33. 8.6.2 Merck KGaA Business Overview
  34. 8.6.3 Merck KGaA Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck KGaA Antithyroid Drug Product Portfolio
  36. 8.6.5 Merck KGaA Recent Developments
  37. 8.7 Teva Pharmaceuticals
  38. 8.7.1 Teva Pharmaceuticals Company Information
  39. 8.7.2 Teva Pharmaceuticals Business Overview
  40. 8.7.3 Teva Pharmaceuticals Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceuticals Antithyroid Drug Product Portfolio
  42. 8.7.5 Teva Pharmaceuticals Recent Developments
  43. 8.8 YanJing Pharm
  44. 8.8.1 YanJing Pharm Company Information
  45. 8.8.2 YanJing Pharm Business Overview
  46. 8.8.3 YanJing Pharm Antithyroid Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 YanJing Pharm Antithyroid Drug Product Portfolio
  48. 8.8.5 YanJing Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antithyroid Drug Value Chain Analysis
  2. 9.1.1 Antithyroid Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antithyroid Drug Sales Mode & Process
  6. 9.2 Antithyroid Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antithyroid Drug Distributors
  9. 9.2.3 Antithyroid Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst